The eye in systemic vasculitis

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 4, Issue 3, 2004, Pages 250-254

  Menezo, Victor ^a   Lightman, Susan ^a,b  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Corticosteroids; Cyclosporin; Ischaemia; Keratitis; Mycophenolate mofetil; Retinitis; Scleritis; Uveitis

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

BLOOD VESSEL DIAMETER; BLOOD VESSEL WALL; DISEASE ASSOCIATION; DISEASE CONTROL; EYE; HUMAN; ISCHEMIA; KERATITIS; NECROSIS; OPTIC NERVE DISEASE; PATHOGENESIS; REVIEW; SCLERITIS; SYSTEMIC VASCULITIS; UVEITIS;

EID: 3042762527     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.4-3-250     Document Type: Review

References (39)

1. Van der Woude FJ, Van Es LA, Daha MR. The role of the c-ANCA antigen in the pathogenesis of Wegener's granulomatosis. A hypothesis based on both humoral and cellular mechanisms. Neth J Med 1990;36:169-71.
2. Spalton DJ, Graham EM, Page NGR, Sanders MD. Ocular changes in limited forms of Wegener's granulomatosis. Br J Ophthalmol 1981;65:553-63.
3. Haynes BF, Fishamn ML, Fauci AS, Wolff SM. The ocular manifestations of Wegener's granulomatosis: fifteen years experience and review of the literature. Am J Med 1977;63:131-41.
4. Woo TL, Francis IC, Wilcsek GA, Coroneo MT et al. Australasian orbital and adnexal Wegener's granulomatosis. Ophthalmology 2001;108:1535-43.
5. Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener's granulomatosis. Ophthalmology 1983;90:279-90.
6. Iida T, Spaide RF, Kantor J. Retinal and choroidal occlusion in Wegener's granulomatosis. Am J Ophthalmol 2002;133:151-2.
7. Inoue K, Kondo M, Inoue M, Ishino H et al. Successful treatment with combination therapy of cyclophosphamide and cyclosporin for late recurrence of Wegener granulomatosis. Arch Intern Med 2000;160:393-4.
8. Haubitz M, Koch KM, Brunkhorst R. Cyclosporin for the prevention of disease in relapsing ANCA-associated vasculitis. Nephrol Dial Transplant 1998;13:2074-6.
9. van der Woude FJ, Schmitt WH, Birk R, Nowack R et al. Immunosuppression in ANCA-associated vasculitis. Transplant Proc 2001;33:2225-6.
10. Soo MP, Chow SK, Tan CT, Nadior N et al. The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms. Lupus 2000;9:511-14.
11. Sainz de la Mata M, Foster CS, Jabbur NS. Scleritis associated with systemic vasculitis diseases. Ophthalmology 1995;102:687-92.
12. Jabs DA, Fine SL, Hochberg MC, Newman SA et al. Severe retinal vasoocclusive disease in systemic lupus erythematous. Arch Ophthalmol 1986;104:558-63.
13. Asherson RA, Mery P, Acheson JF, Harris EN, Hughes GRV. Antiphospholipid antibodies: a risk factor for occlusive vascular disease in lupus erythematosus and 'primary' antiphospholipid syndrome. Ann Rheum Dis 1989;48:358-61.
14. Arevalo JF, Lowder CY, Muci-Mendoza R. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol 2002;13:404-10.
15. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003;30:985-92.
16. Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States. Arthritis Rheum 2003;48:917-26.
17. Tabbara KF, Vera-Cristo CL. Sjögren syndrome. Curr Opin Ophthalmol 2000;11:449-54.
18. Yeh S, Song XJ, Farley W, Li DQ et al. Apoptosis of ocular surface cells in experimentally induced dry eye. Invest Ophthalmol Vis Sci 2003;44:124-9.
19. Hemadi R, Chu W, Foster CS. Keratoconjuctivitis sicca and corneal ulcers. Cornea 1990;9:170-3.
20. Erhardt CC, Munford PA, Venables PJ, Maini RN. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989;48:7-13.
21. Hamideh F, Prete PE. Ophthalmologic manifestations of rheumatic diseases. Semin Arthritis Rheum 2001;30:217-41.
22. Hakin KN, Ham J, Lightman SL. Use of cyclosporin in the management of steroid dependent non-necrotising scleritis. Br J Ophthalmol 1991;75:340-41.
23. Larkin G, Lightman S. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. Ophthalmology 1999;106:370-74.
24. Shah SS, Lowder CY, Schmitt MA, Wilke WS et al. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 1992;99:1419-23.
25. Vote BJ, Elder MJ. Cyanoacrylate glue for corneal perforations: a description of a surgical technique and a review of the literature. Clin Exp Ophthalmol 2000;28:437-42.
26. Criteria for diagnosis of Behcet's disease. International Study Group for Behçet's Disease. Lancet 1990;335:1078-80.
27. Özdal PÇ, Ortaç S, Taşkintuna I, Firat E. Posterior segment involvement in ocular Behçet's disease. Eur J Ophthalmol 2002;12:424-31.
28. Benezra D, Cohen E. Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 1986;70:589-92.
29. Muhaya M, Lightman S, Ikeda E, Mochizuki M et al. Behçet's disease in Japan and in Great Britain: a comparative study. Ocular Immunol Inflamm 2000;8:141-8.
30. Chun YS, Park SJ, Park IK, Chung H, Lee J. The clinical and ocular manifestations of Takayasu arteritis. Retina 2001;21:132-40.
31. Malik KP, Kapoor K, Mehta A, Dadeya S et al. Bilateral anterior ischaemic optic neuropathy in Takayasu arteritis. Indian J Ophthalmol 2002;50:52-4.
32. Messmer EM, Foster CS. Vasculitic peripheral ulcerative keratitis. Surv Ophthalmol 1999;43:379-96.
33. Schmidt D, Lagreze W, Vaith P. Ophthalmoscopic findings in 3 patients with panarteritis nodosa and review of the literature. Klin Monatsbl Augenheilkd 2001;218:44-50.
34. Ford RG, Sickert RG. Central nervous system manifestations of periarteritis nodosa. Neurology 1995;15:114-22.
35. Narag RB Jr, Samuels AJ, Orlin SE, Brent LH. Polyarteritis nodosa complicated by severe progressive scleritis. J Rheumatol 1999;26:1213-14.
36. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 1974;54:271-6.
37. Ohno S, Miyajima T, Higuchi M, Yosida A et al. Ocular manifestations of Kawasaki's disease (mucocutaneous lymph node syndrome). Am J Ophthalmol 1982;93:713-17,
38. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951;27:277-301.
39. Kattah JC, Chrousos GA, Katz PA, McCasland B, Kolsky MP. Anterior ischemic optic neuropathy in Churg-Strauss syndrome. Neurology 1994;44:2200-201.